RU2016111112A - Композиции и способы для лечения патологических состояний носа - Google Patents
Композиции и способы для лечения патологических состояний носа Download PDFInfo
- Publication number
- RU2016111112A RU2016111112A RU2016111112A RU2016111112A RU2016111112A RU 2016111112 A RU2016111112 A RU 2016111112A RU 2016111112 A RU2016111112 A RU 2016111112A RU 2016111112 A RU2016111112 A RU 2016111112A RU 2016111112 A RU2016111112 A RU 2016111112A
- Authority
- RU
- Russia
- Prior art keywords
- amount
- present
- sodium phosphate
- polyethylene glycol
- brimonidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/010,340 | 2013-08-26 | ||
| US14/010,340 US8952011B2 (en) | 2008-08-01 | 2013-08-26 | Compositions and methods for the treatment of nasal conditions |
| PCT/US2014/052242 WO2015031183A1 (fr) | 2013-08-26 | 2014-08-22 | Compositions et méthodes utilisées pour le traitement d'états du nez |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016111112A true RU2016111112A (ru) | 2017-09-29 |
| RU2016111112A3 RU2016111112A3 (fr) | 2018-06-04 |
Family
ID=52587229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016111112A RU2016111112A (ru) | 2013-08-26 | 2014-08-22 | Композиции и способы для лечения патологических состояний носа |
Country Status (4)
| Country | Link |
|---|---|
| BR (1) | BR112016004054A2 (fr) |
| MX (1) | MX2016002485A (fr) |
| RU (1) | RU2016111112A (fr) |
| WO (1) | WO2015031183A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115701993A (zh) * | 2020-11-20 | 2023-02-14 | 成都百裕制药股份有限公司 | 包含银杏内酯类成分的药物组合物和制剂及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000014A2 (fr) * | 2001-06-21 | 2003-01-03 | Altus Biologics, Inc. | Particules de proteine spheriques et methodes de production et d'utilisation desdites particules |
| US20120156244A1 (en) * | 2008-08-01 | 2012-06-21 | Alpha Synergy Development Inc. | Nasal Compositions and Uses Thereof |
-
2014
- 2014-08-22 WO PCT/US2014/052242 patent/WO2015031183A1/fr active Application Filing
- 2014-08-22 BR BR112016004054A patent/BR112016004054A2/pt not_active IP Right Cessation
- 2014-08-22 RU RU2016111112A patent/RU2016111112A/ru not_active Application Discontinuation
- 2014-08-22 MX MX2016002485A patent/MX2016002485A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2016111112A3 (fr) | 2018-06-04 |
| BR112016004054A2 (pt) | 2017-09-12 |
| WO2015031183A1 (fr) | 2015-03-05 |
| MX2016002485A (es) | 2016-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016534153A5 (fr) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| AU2018236805B2 (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
| EA200800147A1 (ru) | Способ получения олмесартан медоксомила | |
| JP2017214429A5 (fr) | ||
| WO2012079092A3 (fr) | Compositions d'undécanoate de testostérone | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| WO2012116290A3 (fr) | Stéroïdes neuroactifs substitués par 17(20)-z-vinylcyano, promédicaments de ceux-ci et procédés de traitement les utilisant | |
| HRP20110058T1 (hr) | 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazin kao spoj sa kombiniranom aktivnošću vezanom za ponovno preuzimanje serotonina i i 5-ht3 i 5ht1a aktivnošću, za liječenje bolova ili rezidualnih simptoma u depresiji vezanih za san i kogniciju | |
| EA201291306A1 (ru) | Состав сухого порошка, содержащий антимускариновое средство | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| JP2013513612A5 (fr) | ||
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| FI3258919T4 (fi) | Nasaalinen jauheformulaatio hypoglykemian hoitoon | |
| RU2013148120A (ru) | Интраназальные фармацевтические композиции на основе бензодиазепина | |
| AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
| NZ620040A (en) | Formulations of deoxycholic acid and salts thereof | |
| EA201490166A1 (ru) | Фторированные арилалкиламинокарбоксамидные производные | |
| EA201101211A1 (ru) | 5-(2-{[6-(2,2-дифтор-2-фенилэтокси)гексил]амино}-l-гидроксиэтил)-8-гидроксихинолин-2(1h)-oh и его применение для лечения легочных заболеваний | |
| RU2016111112A (ru) | Композиции и способы для лечения патологических состояний носа | |
| EA201270411A1 (ru) | Синтетический гибрид гидротальцит-эудрагида урсодеоксихолевой кислоты, содержащая его фармацевтическая композиция и способ их получения | |
| JP2013502449A5 (fr) | ||
| HRP20150387T1 (hr) | Sol kolina i trometamina od likofelona | |
| GR20090100230A (el) | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180925 |